Topic
1 story, newest first.
A study examining UK medical records found that semaglutide, the active ingredient in Ozempic and Wegovy, was associated with a nearly 40% reduction in asthma attacks and a 20% decrease in COPD flare-ups. Scientists suggest anti-inflammatory properties may be responsible, but caution that further trials are needed.
